Towards Healthcare
North America Clinical Trials Market to Reach USD 30.69 Bn by 2034

North America Clinical Trials Market Accelerates in Personalized Therapies

Market insights predict, the North America clinical trials industry is expected to grow from USD 21.76 billion in 2024 to USD 30.69 billion by 2034, driven by a CAGR of 3.50%. A surge in R&D investment and research in academic institutions is fueling the market growth. The United States led the market due to the presence of a strong research environment and the rising chronic cases.

Content

  • Insight Code: 6293
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: October 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Shivani Zoting is a dedicated research analyst specializing in the healthcare industry. With a strong academic foundation, a B.Sc. in Biotechnology and an MBA in Pharmabiotechnology, she brings a unique blend of scientific understanding and market strategy to her research.

Shivani contributes to Towards Healthcare and plays an active role at Precedence Research, where she focuses on delivering in-depth market intelligence, competitive analysis, and trend forecasting across pharmaceuticals, medical devices, digital health, and healthcare services. Her insights support healthcare companies, investors, and policymakers in making data-backed decisions in a highly regulated and rapidly evolving sector.

Additionally, Shivani collaborates with Statifacts, further expanding her healthcare domain reach by engaging in diverse projects across global markets. Her strength lies in transforming complex clinical and commercial data into strategic narratives that help stakeholders navigate the future of healthcare.

Talk to us
FAQ's

The North America clinical trials market is valued at USD 22.52 billion in 2025 and is on track to reach USD 30.69 billion by 2034, witnessing a steady CAGR of 3.50% during the forecast span.

Germany is currently leading the North America clinical trials market due to the presence of a robust research ecosystem & heavy investments in innovations.

The North America clinical trials market includes six segments such as by phase, by therapeutic area, by service type, by end-user/sponsor, by technology, and by country.

Key trends include the accelerating demand for advanced therapies, growth in advanced platforms & research hubs, and innovations in decentralized/virtual trials.

Day 0 in clinical trials is the first day on which a company professionals become aware of a valid adverse event (AE) report meeting the minimum reporting criteria.

US FDA, Health Canada, ClinicalTrials.gov, NIH, WHO, Credevo, NCI, Canada.ca.
Any Questions